Telefon:+86-838-2274206
Aktar
page_banner

L-ewwel grupp ta 'rtirati ta' Sichuan Tongsheng

F'Jannar 2022, Sichuan Tongsheng Biopharmaceutical Co., Ltd ra l-ewwel grupp ta 'rtirati.

hfgd
Kienu: Jiang Xiucai, Wang Zhongpei, Huang Yan.

Ma kellhomx wisq halo, u lanqas atti li jkissru l-art.Iżda kienu ilhom fuq ix-xogħol għal snin sħaħ, jżommu fis-skiet, dedikazzjoni altruista.Huma ddedikaw iż-żgħożija prezzjuża tagħhom lil Tongsheng.L-ispirtu tagħhom se jispira u jirtu ġenerazzjonijiet ta 'nies Tongsheng.
Sinċerament nawguralhom ħajja aktar ikkulurita u kuntenta wara l-irtirar.

Lista tal-prodotti

Derivattivi ta' aċidi amminiċi

Oġġett Isem tal-Komodità CAS Nru
Boc Ipproteġi l-aċidi amminiċi BOC-GLU(OME)-OH 45214-91-3
BOC-GLU(OME)-OME 59279-60-6
BOC-Glycine 4530-20-5
BOC-Gly-Gly 31972-52-8
BOC-L-alanine 15761-38-3
N-Boc-L-tert-Leucine 62965-35-9
BOC-PYR-OET 144978-12-1
Boc-Pyr-OME 108963-96-8
Boc-L-Hydroxyproline 13726-69-7
BOC-Hyp-OME 74844-91-0
BOC-L-Proline 15761-39-4
Boc-Pro-NH2 35150-07-3
BOC-4-OXO-PRO-OME 102195-80-2
N-Boc-4-oxo-L-proline 84348-37-8
Fmoc Ipproteġi l-aċidi amminiċi Fmoc-Ala-OH 35661-39-3
Fmoc-D-Ala-OH 79990-15-1
Fmoc-AEEAc 166108-71-0
Fmoc-Pro-OH 71989-31-6
Fmoc-D-Pro-OH 101555-62-8
Fmoc-Phe-OH 35661-40-6
Fmoc-D-Phe-OH 86123-10-6
Fmoc-Val-OH 68858-20-8
Fmoc-D-Val-OH 84624-17-9
Fmoc-Leu-OH 35661-60-0
Fmoc-D-Leu-OH 114360-54-2
Fmoc-Ile-OH 71989-23-6
Fmoc-Trp-OH 35737-15-6
Oġġett Isem tal-Komodità CAS Nru
Fmoc Ipproteġi l-aċidi amminiċi Fmoc-D-Trp-OH 86123-11-7
Fmoc-Trp(Boc)-OH 143824-78-6
Fmoc-Met-OH 71989-28-1
Fmoc-Gly-OH 29022-11-5
Fmoc-Ser(tBu)-OH 71989-33-8
Fmoc-D-Ser(tBu)-OH 128107-47-1
Fmoc-Tyr(tBu)-OH 71989-38-3
Fmoc-Cys(Trt)-OH 103213-32-7
Fmoc-Asn(Trt)-OH 132388-59-1
Fmoc-Gln(Trt)-OH 132327-80-1
Fmoc-Thr(tBu)-OH 71989-35-0
Fmoc-Asp(OtBu)-OH 71989-14-5
Fmoc-Asp-OtBu 129460-09-9
Fmoc-Glu(OtBu)-OH 71989-18-9
Fmoc-Glu-OtBu 84793-07-7
Fmoc-Lys(Boc)-OH 71989-26-9
Fmoc-Lys-OH 105047-45-8
Fmoc-Lys-OH.HCl 139262-23-0
Fmoc-Arg(Pbf)-OH 154445-77-9
Fmoc-His(Trt)-OH 109425-51-6
Fmoc-Orn(Boc)-OH 109425-55-0
Fmoc-2-Nal-OH 112883-43-9
Fmoc-D-2-Nal-OH 138774-94-4

Intermedji Farmaċewtiċi

Oġġett Isem tal-Komodità CAS Nru
 

 

 

Intermedji kontra d-dijabete

 

 L-Prolinamide 7531-52-4
1-BOC-3-PYRROLIDINONE 101385-93-7
6-CHLORO-3-METHYLURACIL 4318-56-3
(R)-1-Boc-3-Aminopiperidine 188111-79-7
(R)-3-(Boc-Amino)piperidina 309956-78-3
(R)-3-Aminopiperidine dihydrochloride 334618-23-4
(2S)-1-(Chloroacetyl)-2-pirrolidinkarbonitrile 207557-35-5
2-(3R)-3-Piperidinyl-1H-isoindole-1,3(2H)-dione 886588-61-0
Intermedji Antivirus Moc-L-valine 74761-42-5
7-Hydroxy-1-tetralone 22009-38-7
N-Boc-4-oxo-L-proline 84348-37-8
2-Amino-3,5-dibromopyrazine 24241-18-7
N-Methoxy-N-methylacetamide 78191-00-1
2-Bromo-5-jodobenzenemethanol 946525-30-0
N-(Methoxycarbonyl)-L-valyl-L-proline 181827-47-4
(S)-2-ethylbutyl2-aminopropanoatehydrochloride 946511-97-3
(2S,5S)-N-Boc-5-methylpyrrolidine-2-carboxylic acid 334769-80-1
(5S)-N-(Methoxycarbonyl)-L-valyl-5-metil-L-prolina 1335316-40-9
Oġġett Isem tal-Komodità CAS Nru
Intermedji kontra t-tumur 4-Chloropyrrolo[2,3-d]pyrimidine 3680-69-1
3-Hydroxyazetidine hydrochloride 18621-18-6
3-formyl-2-nitrobenzoate tal-metil 138229-59-1
1-(Diphenylmethyl)-3-hydroxyazetidine 18621-17-5
1H-Indazole-7-carboxylic acid metil ester 755752-82-0
5-Benzyl L-glutamate N-carboxyanhydride 3190-71-4
N-Trifluoroacetyl-L-lysine N-carboxyanhydride 42267-27-6
2-[1-(Ethylsulfonyl)-3-azetidinylidene]acetonitrile 1187595-85-2
1-(Diphenylmethyl)-3-hydroxyazetidine hydrochloride 90604-02-7
5-Kloro-6-(klorometil)-2,4(1H,3H)-pirimidinedjon 73742-45-7
tert-Butil4-(5-bromopyrimidin-2-yl)piperazine-1-carboxylate 374930-88-8
3S)-3-(4-Aminophenyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester 1171197-20-8
(3S)-3-(4-Bromophenyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester 1476776-55-2
-(1H-Pyrazol-4-yl)-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine 941685-27-4

Komposti eteroċikliċi

Oġġett Isem tal-Komodità CAS Nru
Komposti tal-piperidina Aċidu L(-)-Pipecolinic 3105-95-1
1-Boc-4-cyanopiperidine 91419-52-2
N-Boc-4-piperidinemethanol 123855-51-6
(S)-3-(Boc-amino)pyrrolidine 122536-76-9
(R)-3-(Boc-amino)pyrrolidine 122536-77-0
5-Chloro-2,3-diphenylpyrazine 41270-66-0
Aċidu N-BOC-piperidine-4-carboxylic 84358-13-4
1-Boc-4-piperidinecarboxaldehyde 137076-22-3
Aċidu (S)-1-Boc-piperidine-2-carboxylic 26250-84-0
Komposti eteroċikliċi tan-nitroġenu 1-Boc-3-forMylazetidine 177947-96-3
Aċidu N-Boc-3-azetidineacetic 183062-96-6
3-Hydroxyazetidine Hydrochloride 18621-18-6
1-BENZHYDRYL-3-AZETIDINOL 18621-17-5
1-Boc-azetidine-3-ylmethanol 142253-56-3
Aċidu 1-N-Boc-3-Azetidinecarboxylic 142253-55-2
AĊIDU 3-AZETIDINEKARBOSSILIKA 36476-78-5
Aċidu 1-Benzhydrylazetidine-3-carboxylic 36476-87-6
1-(DIPHENYLMETHYL)-3-HYDROXYAZETIDINE 90604-02-7
Oġġett Isem tal-Komodità CAS Nru
Komposti Pyrrolidine N-Boc-pyrroline 73286-70-1
(S)-2-Methyl-pyrrolidine 59335-84-1
1-Boc-3-Hydroxypyrrolidine 103057-44-9
(S)-1-Benzyl-3-pyrrolidinol 101385-90-4
(R)-(+)-1-Boc-3-aminopyrrolidine 147081-49-0
(R)-1-Boc-3-hydroxypyrrolidine 109431-87-0
(S)-3-(Boc-amino)pyrrolidine 122536-76-9
(S)-(-)-1-Boc-3-aminopyrrolidine 147081-44-5
(R)-(-)-3-Pyrrolidinol hydrochloride 104706-47-0
1-Boc-3-hydroxymethylpyrrolidine 114214-69-6
(1S,2R)-N-TOSYLEPHEDRINE 127641-25-2
(3R)-(+)-3-(BOC-AMINO)PIRROLIDINA 122536-77-0
(S)-3-Hydroxypyrrolidine hydrochloride 122536-94-1
(R) -1-Boc-3-hydroxymethylpyrrolidine 138108-72-2
(S)-1-Boc-3-hydroxymethylpyrrolidine 199174-24-8
N-(tert-Butoxycarbonyl)-(S)-(+)-3-pirrolidinol 101469-92-5
Oġġett Isem tal-Komodità CAS Nru
Oħrajn 6-(Chloromethyl)uracil 18592-13-7
(S)-(+)-2-Methylpiperazine 74879-18-8
(R)-(-)-2-Methylpiperazine 75336-86-6
(R)-4-Boc-2-methylpiperazine 163765-44-4
(S)-4-N-Boc-2-methylpiperazine 147081-29-6
1-Boc-azetidine-3-ylmethanol 142253-56-3
Aċidu 1-N-Boc-3-Azetidinecarboxylic 142253-55-2
tert-Butyl 3-formylazetidine-1-carboxylate 177947-96-5
2(S)-2-TRIFLUOROMETHYLPYRROLIDINE 119580-41-5
5-Kloro-6-(klorometil)-2,4(1H,3H)-pirimidinedjon 73742-45-7
3-KLOROMETIL-1-METIL-1H-[1,2,4]TRIAZOL 135206-76-7
Ħin tal-post: Mar-15-2022